highly significantp < 0.0001
Myostatin inhibition had no significant effect on BMD from DEXA either on the ground or in flight; however, time following launch was highly significant (p < 0.0001) and time was interactive with spaceflight (p < 0.0001) but not myostatin inhibition treatment.